Locations:
SearchAdvertisement
Clinical trial strategy was developed through research on a gene associated with treatment-resistant prostate cancer
Open-source artificial intelligence technology uses human genetic data to find candidate drugs
Network proximity and EHR analyses identify diabetes drug as a top candidate for risk reduction
Sophisticated in vivo modeling can enhance device development and therapy testing
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Findings underscore need for racial diversity in ongoing and future trials
$14M NIH grant supports research toward medications to prevent progression
Cleveland Clinic is a Founding Partner in Quantum Innovation Hub
Cleveland Clinic’s new Global Director of Vaccine Development outlines plans, priorities
DT-MRI and RNA-FISH show increase in CITED4 promotes healthy architecture of myocardium
Distribution is beginning, but there are questions about effectiveness, supply and adverse events
Advertisement
Advertisement